Literature DB >> 2865143

Brain levels and acute antihypertensive activity of beta-blockers.

P A van Zwieten, P B Timmermans.   

Abstract

The penetration of beta-adrenoceptor blockers into the cerebrospinal fluid and into brain tissue is related to the lipophilicity of these drugs, as reflected by the partition coefficients between octanol and aqueous buffers. However, experimental techniques in animal models show no obvious relationships between the degree of brain penetration and the acute central antihypertensive effect of certain beta-blockers. This discrepancy is demonstrated convincingly by comparative experiments with atenolol and metoprolol. Both drugs are beta 1-selective blockers, and atenolol is highly polar, whereas metoprolol is lipophilic. Both these beta-blockers penetrate the CNS but to differing degrees. The experiments performed with these compounds support other studies described in the literature and do not suggest that there is a central mechanism which underlies the antihypertensive activity of beta-blockers.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865143     DOI: 10.1007/bf00543704

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  Reduction in sympathetic nervous activity as a mechanism for hypotensive effect of propranolol.

Authors:  P J Lewis; G Haeusler
Journal:  Nature       Date:  1975-07-31       Impact factor: 49.962

Review 2.  Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

3.  CNS site of beta-adrenergic blocker-induced hypotension in the cat: a microiontophoretic study of bulbar cardiovascular neurones.

Authors:  J N Sharma; B B Sandrew; S C Wang
Journal:  Neuropharmacology       Date:  1979-01       Impact factor: 5.250

4.  Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomers.

Authors:  L Offerhaus; P A van Zwieten
Journal:  Cardiovasc Res       Date:  1974-07       Impact factor: 10.787

5.  Propranolol in conscious spontaneously hypertensive rats. I. Cardiovascular effects after subcutaneous and intracerebroventricular administration.

Authors:  J F Smits; H van Essen; H A Struyker-Boudier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-10       Impact factor: 3.000

6.  Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol.

Authors:  P A van Zwieten; P B Timmermans
Journal:  J Cardiovasc Pharmacol       Date:  1979 Jan-Feb       Impact factor: 3.105

7.  Presence of beta-adrenoreceptors in the hypothalamus; their importance for the pressor response to hypothalamic stimulation.

Authors:  A Philippu; E Kittel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-04       Impact factor: 3.000

8.  Steady-state disposition of propranolol and its total metabolites in the spontaneously hypertensive rat: chronic subcutaneous vs. intracerebroventricular infusion with osmotic minipumps.

Authors:  J F Smits; H A Struyker-Boudier
Journal:  J Pharmacol Exp Ther       Date:  1979-06       Impact factor: 4.030

9.  Propranolol in conscious spontaneously hypertensive rats. II. Disposition after subcutaneous and intracerebroventricular administration.

Authors:  J M Smits; H A Struyker-Boudier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-10       Impact factor: 3.000

10.  Central antihypertensive activity of propranolol.

Authors:  E J Zawoiski
Journal:  Arch Int Pharmacodyn Ther       Date:  1980-01
View more
  2 in total

Review 1.  CNS-related (side-)effects of beta-blockers with special reference to mechanisms of action.

Authors:  W P Koella
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  Sotalol does not interfere with the antielectroshock action of selected second-generation antiepileptic drugs in mice.

Authors:  Kinga K Borowicz-Reutt; Monika Banach; Monika Rudkowska; Anna Stachniuk
Journal:  Pharmacol Rep       Date:  2021-01-25       Impact factor: 3.024

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.